# Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/direct-oral-anticoagulant-doac-versus-low-molecular-weight-heparin-lmwh-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ang Li,David García,Gary H. Lyman,Marc Carrier |
| Citations | 286 |
| DOI | 10.1016/j.thromres.2018.02.144 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.thrombosisresearch.com/article/S0049384818302160/pdf |
| OpenAlex ID | https://openalex.org/W2792485334 |
| PMID | 29506866 |
| Type | review |
| Year | 2018 |

## Paper authors

- [Ang Li](https://scholariq.org/researchers/ang-li/)

## Paper journal

- [Thrombosis Research](https://scholariq.org/journals/thrombosis-research/)

## Paper primary topic

- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)

## Paper topics

- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Heparin-Induced Thrombocytopenia and Thrombosis](https://scholariq.org/topics/heparin-induced-thrombocytopenia-and-thrombosis/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.